PharmaShots | Incisive News in 3 Shots

Subscribe Now

Plus Therapeutics

Plus Therapeutics’ Rhenium (186Re) Obisbemeda Received the US FDA’s Orphan Drug Designation to Treat Breast Cancer with Leptomeningeal Metastases

Plus Therapeutics’ Rhenium (186Re) Obisbemeda Received the US FDA’s Orphan Drug Designation to Treat Breast Cancer with Leptomenin...

November 6, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us